We serve Chemical Name:5-Hydroxy-2-piperidinone CAS:19365-07-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:5-Hydroxy-2-piperidinone
CAS.NO:19365-07-2
Synonyms:5-Hydroxypiperidin-2-one;5-Hydroxy-2-piperidinone;5-Hydroxy-piperidin-2-one;5-Hydroxy-2-piperidinon;5-Hydroxy-2-piperidon;2-Piperidinone,5-hydroxy;2-Piperidinone, 5-hydroxy-;2-Piperidon-5-ol;5-Hydroxy-piperidin-2-on
Molecular Formula:C5H9NO2
Molecular Weight:115.131
HS Code:2933790090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:352.3±35.0 °C at 760 mmHg
Density:1.2±0.1 g/cm3
Index of Refraction:1.498
PSA:49.33000
Exact Mass:115.063332
LogP:-2.16
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 5-Hydroxypiperidin-2-one chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5-Hydroxy-piperidin-2-on physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Piperidinone, 5-hydroxy- Use and application,5-Hydroxypiperidin-2-one technical grade,usp/ep/jp grade.
Related News: “This is the beginning of the next chapter of growth for BetterUp, and we are not slowing down,” said Alexi Robichaux, CEO and co-founder of BetterUp. “Though we have done business in Europe since 2016, we are committing to a new level of investment in our customers, coaches, and communities by establishing offices in Munich and London. 2-bromo-1-[6,8-dichloro-2-(4-iodo-phenyl)-quinolin-4-yl]-ethanone manufacturers BetterUp is appointing several behavioral scientists, engineers, account executives, marketers, and operations professionals in the region to accelerate product innovation tailored to the European market. The company’s total European headcount is expected to reach 150 in the next year, including representation in France, Benelux, and Sweden. trans-[Pt(DMSO)I2(3-nitro-9-((2-diethylaminoethyl)amino)acridine-N(10))] suppliers Earlier this year, the US Food and Drug Administration approved Verquvo to reduce the risk of cardiovascular death and heart failure hospitalisation, following a hospitalisation for heart failure or need for outpatients intravenous (IV) diuretics in adults with symptomatic chronic heart failure and ejection fraction less than 45%. N-(4-bromophenyl)-3,4-bis(4-fluorophenyl)-N-phenyl-4,5-dihydro-1H-pyrazole-1-carboxamide vendor & factory.
